Xu Y, Fu EL, Clase CM, Mazhar F, et al. GLP-1 receptor agonist versus DPP-4 inhibitor and kidney and cardiovascular outcomes in clinical practice in type-2 diabetes. Kidney Int 2022;101:360-368.
PMID: 34826514